Active
Company Information for EPSILOGEN LTD
WATERFRONT, ARC WEST LONDON MANBRE ROAD, HAMMERSMITH, LONDON, W6 9RH,
|
Company Registration Number
![]() Private Limited Company
Active |
Company Name | ||
---|---|---|
EPSILOGEN LTD | ||
Legal Registered Office | ||
WATERFRONT, ARC WEST LONDON MANBRE ROAD HAMMERSMITH LONDON W6 9RH | ||
Previous Names | ||
|
Company Number | 10295520 | |
---|---|---|
Company ID Number | 10295520 | |
Date formed | 2016-07-26 | |
Country | UNITED KINGDOM | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2023 | |
Account next due | 30/09/2025 | |
Latest return | ||
Return next due | 23/08/2017 | |
Type of accounts | FULL |
Last Datalog update: | 2024-09-08 23:22:52 |
Companies House |
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
VIVIENNE FRANCES COX |
||
PETER MICHAEL FINAN |
||
KYPARISSIA KATIE SIRINAKIS |
||
TIM CRAIG WILSON |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
SOPHIA KARAGIANNIS |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
LEUCID BIO LTD | Director | 2017-06-26 | CURRENT | 2014-11-27 | Active | |
KINSENSUS LIMITED | Director | 2017-06-08 | CURRENT | 2017-06-08 | Active - Proposal to Strike off | |
ETERNYGEN UK LTD. | Director | 2017-03-15 | CURRENT | 2017-03-15 | Active - Proposal to Strike off | |
ADORX THERAPEUTICS LIMITED | Director | 2017-02-24 | CURRENT | 2017-02-24 | Active | |
CLYDE BIOSCIENCES LIMITED | Director | 2015-07-29 | CURRENT | 2012-03-07 | Active | |
ENTERPRISE THERAPEUTICS LTD | Director | 2014-12-08 | CURRENT | 2014-05-02 | Active | |
KNOWLEDGE TRANSFER NETWORK LIMITED | Director | 2014-09-25 | CURRENT | 2013-09-25 | Active | |
THERAVIEW CONSULTING LTD | Director | 2014-07-16 | CURRENT | 2014-07-16 | Active | |
SIRAKOSS LIMITED | Director | 2014-11-24 | CURRENT | 2010-10-04 | Active | |
EPIDAREX CAPITAL PARTNERS LIMITED | Director | 2012-11-30 | CURRENT | 2012-11-30 | Active | |
ALERT BIOSCIENCES LIMITED | Director | 2017-03-09 | CURRENT | 2017-03-09 | Dissolved 2017-11-14 | |
LONGCROSS ADVISERS LIMITED | Director | 2014-10-31 | CURRENT | 2014-10-31 | Active | |
IMMUNART LTD | Director | 2014-10-03 | CURRENT | 2014-10-03 | Dissolved 2018-03-20 | |
EPYNT LIMITED | Director | 2013-03-06 | CURRENT | 2013-03-06 | Dissolved 2018-07-03 |
Date | Document Type | Document Description |
---|---|---|
DIRECTOR APPOINTED SONIA GULATI | ||
04/09/24 STATEMENT OF CAPITAL GBP 7721.7312 | ||
04/09/24 STATEMENT OF CAPITAL GBP 7661.4249 | ||
29/08/24 STATEMENT OF CAPITAL GBP 7601.1186 | ||
29/08/24 STATEMENT OF CAPITAL GBP 6155.403 | ||
CONFIRMATION STATEMENT MADE ON 25/07/24, WITH UPDATES | ||
CESSATION OF EPIDAREX CAPITAL II, LP AS A PERSON OF SIGNIFICANT CONTROL | ||
Notification of a person with significant control statement | ||
CESSATION OF EPIDAREX CAPITAL III UK, LP AS A PERSON OF SIGNIFICANT CONTROL | ||
APPOINTMENT TERMINATED, DIRECTOR DAVID JOHN CHISWELL | ||
15/12/23 STATEMENT OF CAPITAL GBP 4709.6874 | ||
STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 102955200001 | ||
STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 102955200002 | ||
FULL ACCOUNTS MADE UP TO 31/12/22 | ||
REGISTRATION OF A CHARGE / CHARGE CODE 102955200003 | ||
REGISTRATION OF A CHARGE / CHARGE CODE 102955200004 | ||
CONFIRMATION STATEMENT MADE ON 25/07/23, WITH UPDATES | ||
REGISTERED OFFICE CHANGED ON 17/03/23 FROM London Bioscience Innovation Centre 2 Royal College Street London NW1 0NH England | ||
DIRECTOR APPOINTED MISS EMMA JOHNSON | ||
09/02/23 STATEMENT OF CAPITAL GBP 4106.6238 | ||
Memorandum articles filed | ||
Resolutions passed:<ul><li>Resolution passed adopt articles</ul> | ||
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/22, WITH NO UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/21 | |
RES10 | Resolutions passed:
| |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH01 | 24/02/22 STATEMENT OF CAPITAL GBP 4088.2079 | |
PSC07 | CESSATION OF ALEK SAFARIAN AS A PERSON OF SIGNIFICANT CONTROL | |
SH01 | 24/02/22 STATEMENT OF CAPITAL GBP 3789.1353 | |
AP01 | DIRECTOR APPOINTED PHD MARIANNE UTENG | |
AP01 | DIRECTOR APPOINTED DR MARIANNE BJORDAL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR VIVIENNE FRANCES COX | |
Change of details for Mr Alek Safarian as a person with significant control on 2022-01-25 | ||
Director's details changed for Mr Alek Safarian on 2022-01-25 | ||
CH01 | Director's details changed for Mr Alek Safarian on 2022-01-25 | |
PSC04 | Change of details for Mr Alek Safarian as a person with significant control on 2022-01-25 | |
Change of details for Mr Alek Safarian as a person with significant control on 2021-03-01 | ||
Director's details changed for Mr Alek Safarian on 2021-03-01 | ||
CH01 | Director's details changed for Mr Alek Safarian on 2021-03-01 | |
PSC04 | Change of details for Mr Alek Safarian as a person with significant control on 2021-03-01 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/21, WITH UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/20 | |
SH01 | 19/03/21 STATEMENT OF CAPITAL GBP 1979.9446 | |
PSC02 | Notification of Epidarex Capital Iii Uk, Lp as a person with significant control on 2020-03-31 | |
PSC07 | CESSATION OF ALSA UK HOLDINGS LTD AS A PERSON OF SIGNIFICANT CONTROL | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/20, WITH UPDATES | |
PSC01 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL ALEK SAFARIAN | |
PSC02 | Notification of Alsa Uk Holdings Ltd as a person with significant control on 2020-03-31 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/19 | |
RES10 | Resolutions passed:
| |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES15 | CHANGE OF COMPANY NAME 17/04/20 | |
SH01 | 31/03/20 STATEMENT OF CAPITAL GBP 1968.4344 | |
SH01 | 03/10/19 STATEMENT OF CAPITAL GBP 1413.889 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/19, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED DAVID JOHN CHISWELL | |
RES10 | Resolutions passed:
| |
AP01 | DIRECTOR APPOINTED ALEK SAFARIAN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KYPARISSIA KATIE SIRINAKIS | |
SH01 | 29/11/18 STATEMENT OF CAPITAL GBP 1400 | |
SH01 | 22/11/18 STATEMENT OF CAPITAL GBP 1220 | |
PSC07 | CESSATION OF EPIDAREX CAPITAL PARTNERS LIMITED AS A PERSON OF SIGNIFICANT CONTROL | |
PSC07 | CESSATION OF VIVIENNE FRANCES COX AS A PERSON OF SIGNIFICANT CONTROL | |
RP04PSC02 | Second filing of notification of person of significant controlEpidarex Capital Partners Limited | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/18, WITH NO UPDATES | |
RP04AP01 | Second filing of director appointment of Dr Tim Craig Wilson | |
ANNOTATION | Clarification | |
AA | FULL ACCOUNTS MADE UP TO 31/12/17 | |
PSC02 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL EPIDAREX CAPITAL PARTNERS LIMITED | |
PSC02 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL EPIDAREX CAPITAL II LP | |
PSC04 | PSC'S CHANGE OF PARTICULARS / DR SOPHIA KARAGIANNIS / 29/05/2018 | |
PSC04 | PSC'S CHANGE OF PARTICULARS / DR JAMES FREDERICK SPICER / 29/05/2018 | |
CH01 | Director's details changed for Dr Vivienne Frances Cox on 2018-05-03 | |
PSC04 | Change of details for Vivienne Frances Cox as a person with significant control on 2018-05-03 | |
AD01 | REGISTERED OFFICE CHANGED ON 03/05/18 FROM 119 the Hub 300 Kensal Road London W10 5BE England | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 102955200002 | |
AA01 | PREVEXT FROM 31/07/2017 TO 31/12/2017 | |
RP04CS01 | SECOND FILING OF CONFIRMATION STATEMENT DATED 25/07/2017 | |
ANNOTATION | Clarification | |
AP01 | DIRECTOR APPOINTED DR TIM CRAIG WILSON | |
AP01 | DIRECTOR APPOINTED DR TIM CRAIG WILSON | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 102955200001 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/17, WITH UPDATES | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/07/17, WITH UPDATES | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR VIVIENNE FRANCES COX / 16/06/2017 | |
AD01 | REGISTERED OFFICE CHANGED ON 16/06/2017 FROM C/O C/O PENNINGTONS MANCHES LLP APEX PLAZA FORBURY ROAD READING RG1 1AX UNITED KINGDOM | |
LATEST SOC | 21/04/17 STATEMENT OF CAPITAL;GBP 160 | |
SH02 | SUB-DIVISION 31/03/17 | |
SH01 | 31/03/17 STATEMENT OF CAPITAL GBP 800 | |
RES13 | DIRECTORS CONFLICT OF INTEREST. ANY SUCH CONFLICT MAY INFRINGE OR BREACH THE DIRECTORS' DUTY UNDER SECTION 175 OF THE ACT. 31/03/2017 | |
RES01 | ADOPT ARTICLES 31/03/2017 | |
AP01 | DIRECTOR APPOINTED MS KYPARISSIA KATIE SIRINAKIS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR SOPHIA KARAGIANNIS | |
AP01 | DIRECTOR APPOINTED DR PETER MICHAEL FINAN | |
AP01 | DIRECTOR APPOINTED DR VIVIENNE FRANCES COX | |
LATEST SOC | 26/07/16 STATEMENT OF CAPITAL;GBP 160 | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION | |
MODEL ARTICLES | MODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES |
Total # Mortgages/Charges | 4 |
---|---|
Mortgages/Charges outstanding | 2 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 2 |
The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as EPSILOGEN LTD are:
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |